Should I buy NOV Inc. (NOV) stock or is it too late?

NOV Inc. · Energy · price $19

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Susquehanna — 58% of its targets hit on this sector (31 calls tested). It aims for $24 (+27 %), call made on July 31, 2026, maturing on July 31, 2027 (75 d ago).

The 1 reliable analyst $24+27 %

The 7 other firms $22+16 %

How to read it: the 1 reliable firms are not filtered by optimism — 1 aim above the price, 0 below, hence their $24 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on NOV Inc.

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Stifel	60 %	+30.9 %	5	$23 +21%
Susquehanna	50 %	+13.8 %	6	$24 +27%
Citigroup	71 %	+5.6 %	7	$21 +11%
Morgan Stanley	38 %	+3.4 %	8	$20 +5%
Barclays	40 %	-13.8 %	5	$20 +5%
Wells Fargo	60 %	-20.3 %	5	$10 -47%
Goldman Sachs	20 %	-25.0 %	5	$20 +5%
Raymond James	60 %	-1.5 %	5	—

In short — Should you invest in NOV Inc.? Is it too late, still worth it? Analysts are split (43% buy, median target $22, i.e. +16%), and the most reliable on NOV targets even higher. But the stock is volatile. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $22, i.e. +16% from the current price ($19).
The most reliable firm on NOV, RBC Capital (100% hit rate, 3 scored calls), targets $22 (call made on April 29, 2026, maturing on April 29, 2027) (+16%) in its most recent call, and $19 (call made on October 29, 2025, maturing on October 29, 2026) (+0%) in the one coming due soonest.
Pays a dividend (2.7% yield) — regular income on top of potential upside.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 7 ratings, 3 are neutral and 1 is a sell.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.

The analyst consensus on NOV

Median target $22 (+16%) · 7 ratings · Hold consensus

Strong Buy00%

Buy343%

Hold343%

Sell114%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in NOV Inc. now?

We won't decide for you. The facts: 43% of analysts rate it a buy, median target $22 (+16%), and RBC Capital (most reliable on NOV, 100%) targets $22. Weigh that against valuation and volatility. This is not personalized advice.

Is it too late to invest in NOV Inc.?

Not according to analysts: the median target ($22) is still +16% above the current price ($19) (most reliable on NOV: RBC Capital, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is NOV Inc. still worth investing in?

It depends on the gap between the price ($19) and its estimated value: analysts target $22 on median (+16%), with 43% buys (most reliable on NOV: RBC Capital, 100%). Cross-check with their real reliability on NOV and the cautions above. Information, not advice.

What's the main risk in buying NOV?

The consensus is not unanimous: of 7 ratings, 3 are neutral and 1 is a sell.

→ Go deeper: the full NOV Inc. profile (consensus, analyst reliability, price target, performance).